Introduction: Diabetic retinopathy (DR) is the leading cause of vision loss in the working age
population of the developed world. DR encompasses a complex pathology, and one that is …

Abstract Mesenchymal Stem Cells (MSCs) have been studied extensively for the treatment
of several retinal diseases. The therapeutic potential of MSCs lies in its ability to differentiate …

Voretigene neparvovec‐rzyl was recently approved for the treatment of Leber congenital
amaurosis, and the use of gene therapy for eye disease is attracting even greater interest …

Abstract Purpose of Review Diabetic retinopathy (DR), a leading cause of visual impairment
in the developed country, is characterized by vascular lesions and neuronal damage of the …

Diabetic retinopathy (DR) is an important microvascular complication of diabetes mellitus
(DM), causing significant visual impairment worldwide. Current gold standards for retarding …

Age-related macular degeneration (AMD) and diabetic retinopathy (DR) are vascular
diseases with high prevalence, ranking among the leading causes of blindness and vision …

Diabetic retinopathy is a complication of diabetes and a leading cause of vision loss among
working-age adults. To assess whether the Wistar rat with Streptozotocin (STZ)-induced …

Aims Retinopathy is a leading cause of vision impairment in diabetes. Its pathogenesis
involves inflammation, pathological angiogenesis, neuronal and glial dysfunction. The …

Breakdown of the blood-retinal barrier (BRB), as occurs in diabetic retinopathy and other
chronic retinal diseases, results in vasogenic edema and neural tissue damage, causing …

Excessive vasopermeability and angiogenesis compromise vision in diabetic macular
oedema (DME) and diabetic retinopathy (DR). Vasoinhibin is a fragment of the hormone …